<?xml version="1.0" encoding="UTF-8"?><rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://127.0.0.1/xmlui/handle/123456789/547">
<title>Exploration of pharmacological properties of pomegranate and enrichment of antioxidants in pomegranate juice</title>
<link>http://127.0.0.1/xmlui/handle/123456789/547</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://127.0.0.1/xmlui/handle/123456789/548"/>
</rdf:Seq>
</items>
<dc:date>2026-05-12T16:16:23Z</dc:date>
</channel>
<item rdf:about="http://127.0.0.1/xmlui/handle/123456789/548">
<title>Exploration of pharmacological properties of pomegranate and enrichment of antioxidants in pomegranate juice</title>
<link>http://127.0.0.1/xmlui/handle/123456789/548</link>
<description>Exploration of pharmacological properties of pomegranate and enrichment of antioxidants in pomegranate juice
Rout, Suryamani
Pomegranate (Punica granatum L.) is an important plant of tropical and subtropical&#13;
regions of the world. Pomegranate rind/peel contains substantial amounts of polyphenols&#13;
such as ellagic tannins, ellagic acid and gallic acid. Phenolic components extracted from&#13;
pomegranate have shown to possess antioxidant property. However, the role of these&#13;
phenolic components for prevention of diabetic complication and development of&#13;
Advanced Glycation End Products (AGEs) has not yet been established. Most of the&#13;
studies on pharmacological properties of pomegranate peel are restricted towards the&#13;
effect of low molecular weight phenolics. In the present investigation, a polysaccharide&#13;
fraction from pomegranate was isolated and its efficacy in reducing oxidative stress and&#13;
diabetic complications was evaluated. The effect of molecular weight of the&#13;
polysaccharides towards their bioactive potential was also studied.&#13;
In the present study, the effect of a purified phenolic fraction (PLP) isolated from&#13;
pomegranate peel in reducing alloxan induced diabetes and maintaining the serum&#13;
antioxidant level was investigated. It was observed that PLP is a strong inhibitor of&#13;
alloxan induced diabetes owing to its antioxidant activity. The action of PLP in reducing&#13;
the serum glucose level in alloxan induced mice coupled with its α-amylase inhibition&#13;
activity speaks about its possible benefit as an anti-diabetic agent. PLP was found to be a&#13;
mixture of gallic acid and ellagic acid. The protective action of the polysaccharide&#13;
fractions isolated from pomegranate was also elucidated against free radical mediated&#13;
diseases. It was found that polysaccharide fractions are strong inhibitors of the AGEs&#13;
which contribute to different diabetic complications. This study also indicated the effect&#13;
of mass and composition of polysaccharides for its antioxidant activity. The antioxidant&#13;
value was found to increase with increase in mass of the polysaccharide.
</description>
<dc:date>2009-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
